Diabetic nephropathy.
Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.
D000419:Albuminuria / Q000175:diagnosis; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D003928:Diabetic Nephropathies / Q000503:physiopathology* / Q000628:therapy; D004044:Dietary Proteins; D006801:Humans; D006973:Hypertension / Q000517:prevention & control*; D011785:Quality Assurance, Health Care
D000959:Antihypertensive Agents; D001786:Blood Glucose; D004044:Dietary Proteins